nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.00468	0.00468	CcSEcCtD
Vildagliptin—Weight increased—Ethinyl Estradiol—osteoporosis	0.00459	0.00459	CcSEcCtD
Vildagliptin—Angioedema—Etidronic acid—osteoporosis	0.00458	0.00458	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Risedronate—osteoporosis	0.00457	0.00457	CcSEcCtD
Vildagliptin—Angiopathy—Estropipate—osteoporosis	0.00451	0.00451	CcSEcCtD
Vildagliptin—Infestation—Ethinyl Estradiol—osteoporosis	0.00449	0.00449	CcSEcCtD
Vildagliptin—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00449	0.00449	CcSEcCtD
Vildagliptin—Asthenia—Calcium Acetate—osteoporosis	0.00447	0.00447	CcSEcCtD
Vildagliptin—Nasopharyngitis—Zoledronate—osteoporosis	0.00441	0.00441	CcSEcCtD
Vildagliptin—Infestation NOS—Risedronate—osteoporosis	0.00438	0.00438	CcSEcCtD
Vildagliptin—Infestation—Risedronate—osteoporosis	0.00438	0.00438	CcSEcCtD
Vildagliptin—Angiopathy—Raloxifene—osteoporosis	0.00437	0.00437	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Estradiol—osteoporosis	0.00435	0.00435	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Pamidronate—osteoporosis	0.00434	0.00434	CcSEcCtD
Vildagliptin—Malnutrition—Estropipate—osteoporosis	0.00433	0.00433	CcSEcCtD
Vildagliptin—Angiopathy—Ibandronate—osteoporosis	0.00433	0.00433	CcSEcCtD
Vildagliptin—Chills—Ibandronate—osteoporosis	0.00428	0.00428	CcSEcCtD
Vildagliptin—Flatulence—Estropipate—osteoporosis	0.00427	0.00427	CcSEcCtD
Vildagliptin—Arthralgia—Etidronic acid—osteoporosis	0.00426	0.00426	CcSEcCtD
Vildagliptin—Diarrhoea—Calcium Acetate—osteoporosis	0.00426	0.00426	CcSEcCtD
Vildagliptin—Flatulence—Alendronate—osteoporosis	0.0042	0.0042	CcSEcCtD
Vildagliptin—Infestation NOS—Pamidronate—osteoporosis	0.00416	0.00416	CcSEcCtD
Vildagliptin—Infestation—Pamidronate—osteoporosis	0.00416	0.00416	CcSEcCtD
Vildagliptin—Malnutrition—Ibandronate—osteoporosis	0.00415	0.00415	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Risedronate—osteoporosis	0.00414	0.00414	CcSEcCtD
Vildagliptin—Flatulence—Raloxifene—osteoporosis	0.00413	0.00413	CcSEcCtD
Vildagliptin—Dizziness—Calcium Acetate—osteoporosis	0.00412	0.00412	CcSEcCtD
Vildagliptin—Flatulence—Ibandronate—osteoporosis	0.00409	0.00409	CcSEcCtD
Vildagliptin—Infection—Etidronic acid—osteoporosis	0.00406	0.00406	CcSEcCtD
Vildagliptin—Pancreatitis—Conjugated Estrogens—osteoporosis	0.00403	0.00403	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Zoledronate—osteoporosis	0.00397	0.00397	CcSEcCtD
Vildagliptin—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00396	0.00396	CcSEcCtD
Vildagliptin—Angioedema—Estropipate—osteoporosis	0.00396	0.00396	CcSEcCtD
Vildagliptin—Asthenia—Ergocalciferol—osteoporosis	0.00395	0.00395	CcSEcCtD
Vildagliptin—Angioedema—Alendronate—osteoporosis	0.0039	0.0039	CcSEcCtD
Vildagliptin—Weight increased—Zoledronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Vildagliptin—Oedema peripheral—Risedronate—osteoporosis	0.00387	0.00387	CcSEcCtD
Vildagliptin—Connective tissue disorder—Risedronate—osteoporosis	0.00386	0.00386	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00382	0.00382	CcSEcCtD
Vildagliptin—Infestation NOS—Zoledronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Vildagliptin—Infestation—Zoledronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Vildagliptin—Angioedema—Ibandronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Vildagliptin—Weight increased—Conjugated Estrogens—osteoporosis	0.00374	0.00374	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00372	0.00372	CcSEcCtD
Vildagliptin—Nausea—Calcium Acetate—osteoporosis	0.0037	0.0037	CcSEcCtD
Vildagliptin—Arthralgia—Estropipate—osteoporosis	0.00369	0.00369	CcSEcCtD
Vildagliptin—Connective tissue disorder—Pamidronate—osteoporosis	0.00367	0.00367	CcSEcCtD
Vildagliptin—Infestation NOS—Conjugated Estrogens—osteoporosis	0.00366	0.00366	CcSEcCtD
Vildagliptin—Infestation—Conjugated Estrogens—osteoporosis	0.00366	0.00366	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00366	0.00366	CcSEcCtD
Vildagliptin—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00366	0.00366	CcSEcCtD
Vildagliptin—Arthralgia—Raloxifene—osteoporosis	0.00357	0.00357	CcSEcCtD
Vildagliptin—Angiopathy—Risedronate—osteoporosis	0.00357	0.00357	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00355	0.00355	CcSEcCtD
Vildagliptin—Arthralgia—Ibandronate—osteoporosis	0.00354	0.00354	CcSEcCtD
Vildagliptin—Oedema—Estropipate—osteoporosis	0.00354	0.00354	CcSEcCtD
Vildagliptin—Infection—Estropipate—osteoporosis	0.00351	0.00351	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00351	0.00351	CcSEcCtD
Vildagliptin—Liver function test abnormal—Estradiol—osteoporosis	0.00351	0.00351	CcSEcCtD
Vildagliptin—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00351	0.00351	CcSEcCtD
Vildagliptin—Constipation—Etidronic acid—osteoporosis	0.00349	0.00349	CcSEcCtD
Vildagliptin—Nervous system disorder—Estropipate—osteoporosis	0.00347	0.00347	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00346	0.00346	CcSEcCtD
Vildagliptin—Infection—Alendronate—osteoporosis	0.00346	0.00346	CcSEcCtD
Vildagliptin—Skin disorder—Estropipate—osteoporosis	0.00343	0.00343	CcSEcCtD
Vildagliptin—Malnutrition—Risedronate—osteoporosis	0.00342	0.00342	CcSEcCtD
Vildagliptin—Infection—Raloxifene—osteoporosis	0.0034	0.0034	CcSEcCtD
Vildagliptin—Nasopharyngitis—Estradiol—osteoporosis	0.0034	0.0034	CcSEcCtD
Vildagliptin—Angiopathy—Pamidronate—osteoporosis	0.00339	0.00339	CcSEcCtD
Vildagliptin—Flatulence—Risedronate—osteoporosis	0.00337	0.00337	CcSEcCtD
Vildagliptin—Infection—Ibandronate—osteoporosis	0.00337	0.00337	CcSEcCtD
Vildagliptin—Oedema peripheral—Zoledronate—osteoporosis	0.00336	0.00336	CcSEcCtD
Vildagliptin—Nervous system disorder—Raloxifene—osteoporosis	0.00336	0.00336	CcSEcCtD
Vildagliptin—Connective tissue disorder—Zoledronate—osteoporosis	0.00336	0.00336	CcSEcCtD
Vildagliptin—Chills—Pamidronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Vildagliptin—Skin disorder—Raloxifene—osteoporosis	0.00333	0.00333	CcSEcCtD
Vildagliptin—Nervous system disorder—Ibandronate—osteoporosis	0.00332	0.00332	CcSEcCtD
Vildagliptin—Hyperhidrosis—Raloxifene—osteoporosis	0.00331	0.00331	CcSEcCtD
Vildagliptin—Skin disorder—Ibandronate—osteoporosis	0.00329	0.00329	CcSEcCtD
Vildagliptin—Hyperhidrosis—Ibandronate—osteoporosis	0.00328	0.00328	CcSEcCtD
Vildagliptin—Nausea—Ergocalciferol—osteoporosis	0.00327	0.00327	CcSEcCtD
Vildagliptin—Malnutrition—Pamidronate—osteoporosis	0.00325	0.00325	CcSEcCtD
Vildagliptin—Urticaria—Etidronic acid—osteoporosis	0.00325	0.00325	CcSEcCtD
Vildagliptin—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Skin disorder—Calcitriol—osteoporosis	0.00322	0.00322	CcSEcCtD
Vildagliptin—Pancreatitis—Estradiol—osteoporosis	0.00322	0.00322	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00322	0.00322	CcSEcCtD
Vildagliptin—Angioedema—Ethinyl Estradiol—osteoporosis	0.00321	0.00321	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00317	0.00317	CcSEcCtD
Vildagliptin—Angioedema—Risedronate—osteoporosis	0.00313	0.00313	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00312	0.00312	CcSEcCtD
Vildagliptin—Angiopathy—Zoledronate—osteoporosis	0.0031	0.0031	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00309	0.00309	CcSEcCtD
Vildagliptin—Chills—Zoledronate—osteoporosis	0.00306	0.00306	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Estradiol—osteoporosis	0.00306	0.00306	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Estropipate—osteoporosis	0.00305	0.00305	CcSEcCtD
Vildagliptin—Fatigue—Estropipate—osteoporosis	0.00305	0.00305	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00302	0.00302	CcSEcCtD
Vildagliptin—Constipation—Estropipate—osteoporosis	0.00302	0.00302	CcSEcCtD
Vildagliptin—Weight increased—Estradiol—osteoporosis	0.00299	0.00299	CcSEcCtD
Vildagliptin—Angiopathy—Conjugated Estrogens—osteoporosis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Constipation—Alendronate—osteoporosis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Angioedema—Pamidronate—osteoporosis	0.00297	0.00297	CcSEcCtD
Vildagliptin—Malnutrition—Zoledronate—osteoporosis	0.00297	0.00297	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00297	0.00297	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00296	0.00296	CcSEcCtD
Vildagliptin—Infestation—Estradiol—osteoporosis	0.00293	0.00293	CcSEcCtD
Vildagliptin—Infestation NOS—Estradiol—osteoporosis	0.00293	0.00293	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Vildagliptin—Fatigue—Ibandronate—osteoporosis	0.00292	0.00292	CcSEcCtD
Vildagliptin—Arthralgia—Risedronate—osteoporosis	0.00291	0.00291	CcSEcCtD
Vildagliptin—Constipation—Ibandronate—osteoporosis	0.0029	0.0029	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00289	0.00289	CcSEcCtD
Vildagliptin—Oedema—Ethinyl Estradiol—osteoporosis	0.00287	0.00287	CcSEcCtD
Vildagliptin—Malnutrition—Conjugated Estrogens—osteoporosis	0.00286	0.00286	CcSEcCtD
Vildagliptin—Infection—Ethinyl Estradiol—osteoporosis	0.00285	0.00285	CcSEcCtD
Vildagliptin—Constipation—Calcitriol—osteoporosis	0.00284	0.00284	CcSEcCtD
Vildagliptin—Flatulence—Conjugated Estrogens—osteoporosis	0.00282	0.00282	CcSEcCtD
Vildagliptin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00281	0.00281	CcSEcCtD
Vildagliptin—Urticaria—Estropipate—osteoporosis	0.00281	0.00281	CcSEcCtD
Vildagliptin—Diarrhoea—Etidronic acid—osteoporosis	0.0028	0.0028	CcSEcCtD
Vildagliptin—Tremor—Zoledronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Vildagliptin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00278	0.00278	CcSEcCtD
Vildagliptin—Infection—Risedronate—osteoporosis	0.00278	0.00278	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Estradiol—osteoporosis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Arthralgia—Pamidronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Urticaria—Alendronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Nervous system disorder—Risedronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Vildagliptin—Angioedema—Zoledronate—osteoporosis	0.00272	0.00272	CcSEcCtD
Vildagliptin—Skin disorder—Risedronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Vildagliptin—Urticaria—Ibandronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Vildagliptin—Oedema—Pamidronate—osteoporosis	0.00266	0.00266	CcSEcCtD
Vildagliptin—Infection—Pamidronate—osteoporosis	0.00264	0.00264	CcSEcCtD
Vildagliptin—Urticaria—Calcitriol—osteoporosis	0.00264	0.00264	CcSEcCtD
Vildagliptin—Hepatitis—Estradiol—osteoporosis	0.00263	0.00263	CcSEcCtD
Vildagliptin—Angioedema—Conjugated Estrogens—osteoporosis	0.00262	0.00262	CcSEcCtD
Vildagliptin—Nervous system disorder—Pamidronate—osteoporosis	0.0026	0.0026	CcSEcCtD
Vildagliptin—Oedema peripheral—Estradiol—osteoporosis	0.00259	0.00259	CcSEcCtD
Vildagliptin—Connective tissue disorder—Estradiol—osteoporosis	0.00259	0.00259	CcSEcCtD
Vildagliptin—Hyperhidrosis—Pamidronate—osteoporosis	0.00257	0.00257	CcSEcCtD
Vildagliptin—Headache—Etidronic acid—osteoporosis	0.00256	0.00256	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00255	0.00255	CcSEcCtD
Vildagliptin—Asthenia—Estropipate—osteoporosis	0.00254	0.00254	CcSEcCtD
Vildagliptin—Arthralgia—Zoledronate—osteoporosis	0.00253	0.00253	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00251	0.00251	CcSEcCtD
Vildagliptin—Asthenia—Alendronate—osteoporosis	0.0025	0.0025	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00247	0.00247	CcSEcCtD
Vildagliptin—Fatigue—Ethinyl Estradiol—osteoporosis	0.00247	0.00247	CcSEcCtD
Vildagliptin—Constipation—Ethinyl Estradiol—osteoporosis	0.00245	0.00245	CcSEcCtD
Vildagliptin—Arthralgia—Conjugated Estrogens—osteoporosis	0.00244	0.00244	CcSEcCtD
Vildagliptin—Asthenia—Ibandronate—osteoporosis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Nausea—Etidronic acid—osteoporosis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Oedema—Zoledronate—osteoporosis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00242	0.00242	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Vildagliptin—Diarrhoea—Estropipate—osteoporosis	0.00242	0.00242	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Risedronate—osteoporosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Infection—Zoledronate—osteoporosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Fatigue—Risedronate—osteoporosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Constipation—Risedronate—osteoporosis	0.00239	0.00239	CcSEcCtD
Vildagliptin—Angiopathy—Estradiol—osteoporosis	0.00239	0.00239	CcSEcCtD
Vildagliptin—Diarrhoea—Alendronate—osteoporosis	0.00238	0.00238	CcSEcCtD
Vildagliptin—Asthenia—Calcitriol—osteoporosis	0.00238	0.00238	CcSEcCtD
Vildagliptin—Nervous system disorder—Zoledronate—osteoporosis	0.00238	0.00238	CcSEcCtD
Vildagliptin—Chills—Estradiol—osteoporosis	0.00236	0.00236	CcSEcCtD
Vildagliptin—Skin disorder—Zoledronate—osteoporosis	0.00236	0.00236	CcSEcCtD
Vildagliptin—Hyperhidrosis—Zoledronate—osteoporosis	0.00235	0.00235	CcSEcCtD
Vildagliptin—Diarrhoea—Raloxifene—osteoporosis	0.00234	0.00234	CcSEcCtD
Vildagliptin—Dizziness—Estropipate—osteoporosis	0.00234	0.00234	CcSEcCtD
Vildagliptin—Oedema—Conjugated Estrogens—osteoporosis	0.00234	0.00234	CcSEcCtD
Vildagliptin—Infection—Conjugated Estrogens—osteoporosis	0.00232	0.00232	CcSEcCtD
Vildagliptin—Diarrhoea—Ibandronate—osteoporosis	0.00232	0.00232	CcSEcCtD
Vildagliptin—Dizziness—Alendronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00229	0.00229	CcSEcCtD
Vildagliptin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00229	0.00229	CcSEcCtD
Vildagliptin—Malnutrition—Estradiol—osteoporosis	0.00229	0.00229	CcSEcCtD
Vildagliptin—Fatigue—Pamidronate—osteoporosis	0.00229	0.00229	CcSEcCtD
Vildagliptin—Urticaria—Ethinyl Estradiol—osteoporosis	0.00228	0.00228	CcSEcCtD
Vildagliptin—Constipation—Pamidronate—osteoporosis	0.00227	0.00227	CcSEcCtD
Vildagliptin—Diarrhoea—Calcitriol—osteoporosis	0.00227	0.00227	CcSEcCtD
Vildagliptin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00227	0.00227	CcSEcCtD
Vildagliptin—Dizziness—Raloxifene—osteoporosis	0.00226	0.00226	CcSEcCtD
Vildagliptin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00226	0.00226	CcSEcCtD
Vildagliptin—Flatulence—Estradiol—osteoporosis	0.00226	0.00226	CcSEcCtD
Vildagliptin—Dizziness—Ibandronate—osteoporosis	0.00224	0.00224	CcSEcCtD
Vildagliptin—Urticaria—Risedronate—osteoporosis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Headache—Estropipate—osteoporosis	0.00221	0.00221	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00221	0.00221	CcSEcCtD
Vildagliptin—Headache—Alendronate—osteoporosis	0.00218	0.00218	CcSEcCtD
Vildagliptin—Tremor—Estradiol—osteoporosis	0.00215	0.00215	CcSEcCtD
Vildagliptin—Headache—Raloxifene—osteoporosis	0.00215	0.00215	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00213	0.00213	CcSEcCtD
Vildagliptin—Headache—Ibandronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Vildagliptin—Nausea—Estropipate—osteoporosis	0.0021	0.0021	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Vildagliptin—Angioedema—Estradiol—osteoporosis	0.00209	0.00209	CcSEcCtD
Vildagliptin—Fatigue—Zoledronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Vildagliptin—Headache—Calcitriol—osteoporosis	0.00208	0.00208	CcSEcCtD
Vildagliptin—Constipation—Zoledronate—osteoporosis	0.00207	0.00207	CcSEcCtD
Vildagliptin—Nausea—Alendronate—osteoporosis	0.00207	0.00207	CcSEcCtD
Vildagliptin—Asthenia—Ethinyl Estradiol—osteoporosis	0.00206	0.00206	CcSEcCtD
Vildagliptin—Nausea—Raloxifene—osteoporosis	0.00203	0.00203	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00202	0.00202	CcSEcCtD
Vildagliptin—Fatigue—Conjugated Estrogens—osteoporosis	0.00201	0.00201	CcSEcCtD
Vildagliptin—Nausea—Ibandronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Vildagliptin—Asthenia—Risedronate—osteoporosis	0.002	0.002	CcSEcCtD
Vildagliptin—Constipation—Conjugated Estrogens—osteoporosis	0.002	0.002	CcSEcCtD
Vildagliptin—Nausea—Calcitriol—osteoporosis	0.00197	0.00197	CcSEcCtD
Vildagliptin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00196	0.00196	CcSEcCtD
Vildagliptin—Arthralgia—Estradiol—osteoporosis	0.00195	0.00195	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00194	0.00194	CcSEcCtD
Vildagliptin—Urticaria—Zoledronate—osteoporosis	0.00193	0.00193	CcSEcCtD
Vildagliptin—Diarrhoea—Risedronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Vildagliptin—Asthenia—Pamidronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Vildagliptin—Dizziness—Ethinyl Estradiol—osteoporosis	0.0019	0.0019	CcSEcCtD
Vildagliptin—Oedema—Estradiol—osteoporosis	0.00187	0.00187	CcSEcCtD
Vildagliptin—Infection—Estradiol—osteoporosis	0.00186	0.00186	CcSEcCtD
Vildagliptin—Urticaria—Conjugated Estrogens—osteoporosis	0.00186	0.00186	CcSEcCtD
Vildagliptin—Dizziness—Risedronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Vildagliptin—Nervous system disorder—Estradiol—osteoporosis	0.00183	0.00183	CcSEcCtD
Vildagliptin—Diarrhoea—Pamidronate—osteoporosis	0.00182	0.00182	CcSEcCtD
Vildagliptin—Skin disorder—Estradiol—osteoporosis	0.00182	0.00182	CcSEcCtD
Vildagliptin—Hyperhidrosis—Estradiol—osteoporosis	0.00181	0.00181	CcSEcCtD
Vildagliptin—Headache—Ethinyl Estradiol—osteoporosis	0.0018	0.0018	CcSEcCtD
Vildagliptin—Dizziness—Pamidronate—osteoporosis	0.00176	0.00176	CcSEcCtD
Vildagliptin—Headache—Risedronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Asthenia—Zoledronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Vildagliptin—Nausea—Ethinyl Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Vildagliptin—Asthenia—Conjugated Estrogens—osteoporosis	0.00168	0.00168	CcSEcCtD
Vildagliptin—Headache—Pamidronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Diarrhoea—Zoledronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Nausea—Risedronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Estradiol—osteoporosis	0.00161	0.00161	CcSEcCtD
Vildagliptin—Fatigue—Estradiol—osteoporosis	0.00161	0.00161	CcSEcCtD
Vildagliptin—Dizziness—Zoledronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Vildagliptin—Constipation—Estradiol—osteoporosis	0.0016	0.0016	CcSEcCtD
Vildagliptin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.0016	0.0016	CcSEcCtD
Vildagliptin—Nausea—Pamidronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Vildagliptin—Dizziness—Conjugated Estrogens—osteoporosis	0.00154	0.00154	CcSEcCtD
Vildagliptin—Headache—Zoledronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Vildagliptin—Urticaria—Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Vildagliptin—Headache—Conjugated Estrogens—osteoporosis	0.00146	0.00146	CcSEcCtD
Vildagliptin—Nausea—Zoledronate—osteoporosis	0.00144	0.00144	CcSEcCtD
Vildagliptin—Nausea—Conjugated Estrogens—osteoporosis	0.00139	0.00139	CcSEcCtD
Vildagliptin—Asthenia—Estradiol—osteoporosis	0.00134	0.00134	CcSEcCtD
Vildagliptin—Diarrhoea—Estradiol—osteoporosis	0.00128	0.00128	CcSEcCtD
Vildagliptin—Dizziness—Estradiol—osteoporosis	0.00124	0.00124	CcSEcCtD
Vildagliptin—Headache—Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Vildagliptin—Nausea—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
